P001
EXCEPTIONAL RESPONSE TO MULTIPLE-RECURRENT AND METASTATIC HER-2 POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA WITH A PERSONALIZED TREATMENT APPROACH.
Cancer Biology
Nolan B Seim, MD1, Stephen Y Kang, MD1, Riley G Jones, MD2, Manish S Bhandari, MD2, Theodoros N Teknos, MD1
1Department of Otolaryngology-Head and Neck Surgery, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State University Wexner Medical Center, Columbus Ohio, 2Department of Internal Medicine, Division of Medical Oncology, The Christ Hospital, Cincinnati, Ohio
P002
ROLE OF NANOG IN THE RADIORESISTANCE OF HEAD AND NECK CANCER
Sei Young Lee, MD1, Se-Heon Kim, MD2, Yunha Kim, PhD1
1Department of Otolaryngology, Chung-Ang University College of Medicine, 2Department of Otorhinolaryngology, Yonsei University College of Medicine
P003
WHOLE-EXOME SEQUENCING ANALYSIS OF NASOPHARYNGEAL CARCINOMA
Yong Liu, PhD, MD, Xin Zhang, Prof, PhD, MD, Ming Wei, Gangcai Zhu, Meilin Huang, She Li
Xiangya Hospital, Central South University
P004
INVASION OF HEAD AND NECK SQUAMOUS CELL CANCER CELLS REQUIRES TENASCIN-C EXPRESSION
Carissa M Thomas, MD, PhD, Stephen Keysar, PhD, Bettina Miller, Magdalena Glogowska, John I Song, MD, Antonio Jimeno, MD, PhD
University of Colorado School of Medicine
P005
ANALYSIS OF THE LOSS OF CASPASE 8 IN HNSCC USING 3D ORGANOTYPIC CULTURES
Antje Lindemann, PhD, Burak Uzunparmak, Jeffrey N Myers, Curtis R Pickering
The University of Texas MD Anderson Cancer Center
P006
GENOME METHYLATION IN ORAL CAVITY CARCINOMAS
1, Mariana B dos Reis, Dr1, Mateus C Barros Filho, Dr1, Fábio A Marchi, Dr1, Skirant N Ambatipudi, PhD2, Zdenko N Herceg, PhD2, Silvia R Rogatto, PhD1, Luiz P Kowalski, PhD1
1AC Camargo Cancer Center, 2International Agency for Research on Cancer (IARC)
P007
MIR-520B INHIBITS THE MALIGNANCY OF HEAD-NECK CANCER THROUGH THE SUPPRESSION OF CANCER STEMNESS BY TARGETING CD44
Ann-Joy Cheng, PhD1, Ya-Ching Lu1, Joseph T Chang, MD2
1Chang Gung University, 2Chang Gung Memorial Hospital-Linko
P008
CANCER STEM CELL NICHE CORRELATES WITH MALIGNANT PROGRESSION
Subin t Surendran1, Gangotri Siddappa2, Ravindra D Ravi2, Christina Mimikos1, Wesley L Hicks1, Amritha Suresh3, Moni A Kuriakose1
1Head and Neck Surgery, Roswell Park Cancer Institute, Buffalo, New York, 14263, 2Mazumdar Shaw Centre for Translational Research, Mazumdar Shaw Medical Centre, Narayana Hrudayalaya, Bangalore, 560099, 3Mazumdar Shaw Medical Center- Roswell Park Collaboration Program, Buffalo, New York 14263
P009
FEASIBILITY OF RECOMBINANT SENDAI VIRUS VECTOR MEDIATED SENTINEL LYMPH NODE TARGETED GENE TRANSFER IN AN ORTHOTOPIC NUDE MOUSE MODEL OF HEAD & NECK SQUAMOUS CELL CARCINOMA
Yuya Tanaka, MD1, Koji Araki, MD, PhD1, Shingo Tanaka, MD1, Yoshihiro Miyagawa, MD1, Hiroshi Suzuki, MD1, Daisuke Kamide, MD, PhD1, Taku Yamashita, MD, PhD1, Masayuki Tomifuji, MD, PhD1, Yasuji Ueda, PhD2, Makoto Inoue, PhD2, Akihiro Shiotani, MD, PhD1
1National Defense Medical College, 2ID Pharma Co., Ltd.
P010
PROGNOSTIC VALUE OF ABERRANT PROMOTER HYPERMETHYLATION OF TUMOR-RELATED GENES IN EARLY-STAGE HEAD AND NECK CANCER
Kiyoshi Misawa1, Takeharu Kanazawa2, Yuki Misawa1, Hiroyuki Mineta1
1Hamamatsu University School of Medicine, 2Jichi Medical University, Tochigi
AHNS Annual Meeting
July 16-20, 2016 Washington State Convention Center Seattle, WA
Tips on Using this Site
Locate an abstract by entering any author's surname into the search box. You may also search by keyword or program ID number.
Broaden your search by typing only a few letters of a keyword; however, do not append the wildcard “*” to a search string.
Type too small? In most browsers, press Control “+” to enlarge type size. Reset by pressing Control “0”.
Results. To view an abstract, click on a title within results. Presenters’ names are underlined among the list of authors.
Browser Compatibility
For the best user experience on this or any website, it is important that your browser remain up-to-date with current standards.
We support Microsoft Internet Explorer 10+, Microsoft Edge, Mozilla Firefox, Google Chrome and any other modern web browser compatible with HTML5 and CSS3.